Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 The characteristics of study samples

From: Prevalence of CCR5delta32 in Northeastern Iran

 

Wild type

Mutantb

Heterozygote

Total

Sexa

46.1 (m), 53.9 (f)

100.0 (f)

45.5 (m), 54.5 (f)

45.9 (m), 54.1 (f)

Age (yr)

46.09 ± 7.25

37.00

46.45 ± 8.12

46.1 ± 7.27

Weight (Kg)

71.92 ± 13.27

61.2

77.11 ± 11.8

72.04 ± 13.2

Height (m)

1.62 ± .09

1.51

1.64 ± .10

1.62 ± .1

BMI

27.5 ± 4.79

26.84

29.21 ± 6.29

27.5 ± 4.8

Inflammatory marker

 Hs-CRP

1.64 (3.11–1.00)

0.75

1.45 (3.40–0.87)

1.62 (3.10–1.00)

Smoking

 Non-smokera

63.5

100.0

81.8

64.1

 Ex-smokera

10.0

0.0

18.2

9.7

 Current smokera

26.5

0.0

0.0

26.2

Diabetes

 Diabetic conditiona

15.4

0.0

20.0

15.5

Biochemical parameters

 Glucose (mg/dL)

82.0 (92.0–74.5)

71.00

82.0 (96.0–74.0)

82.0 (92.0–74.5)

 Cholesterol (mg/dL)

187.00 (214.00–163.00)

175.00

182.00 (233.00–153.00)

187.00 (214.00–163.00

 HDL (mg/dL)

41.5 ± 9.0

39.30

41.43 ± 10.82

41.5 ± 9.0

 Triglyceride (mg/dL)

116.0 (172.0–81.50)

74.00

92.00 (210.00–74.00)

115.0 (172.0–81.50)

 LDL (mg/dL)

118.88 (141.6–95.75)

102.06

121.88 (160.80–84.00)

118.92 (141.6–95.75)

  1. The results showed as mean ± SD and median (IQ3-IQ1) for normal and abnormal distribution data, respectively. a The numbers represent percentage of prevalence; b mutant group have only one subject